New JAMA studies examine whether routine colonoscopies and low‑dose thyroid drugs benefit older adults, raising questions about risks, costs and continued use.
Comparing Tesla and Rivian stock in 2026? See the analysis of these two companies to find the better investment for your portfolio needs.
European automakers are under pressure and need restructuring. But global turmoil offers relief; increased defense spending presents a potentially lucrative lifeline.
Trump promises maximum consumer choice in health care. Yet, he is making it harder to access home -based care favored by older adults and young people with disabilities.
As Google warns that the elliptic curve cryptography protecting the Bitcoin blockchain might be at risk sooner than expected, how close are we to cryptogeddon?
Anthropic’s invite-only rollout of Project Glasswing shows how frontier AI is becoming a premium enterprise product, shaped by scarcity, safety and market strategy.
China’s BYD suffered a rare setback last year when its earnings fell nearly 20%, but Europe remains a prime target.
The San Francisco fintech announced a new set of rewards–including cash back on one category of spending–in a bid to boost new-user growth.
The San Francisco fintech has significantly revised its product descriptions, addressing some of the issues Forbes previously reported as misleading to consumers.
Data centers have turned some electricity producers, like Constellation and Talen, into growth stocks.